Johnson & Johnson announced sales of $15.2 billion for the second quarter of 2009, a decrease of 7.4% as compared to the second quarter of 2008. Operational results declined 1.4% and the negative impact of currency was 6.0%. Domestic sales declined 6.7%, while international sales declined 8.0%, reflecting operational growth of 3.9% and a negative currency impact of 11.9%. Worldwide consumer sales posted operational growth of 3.1%. According to the company, Listerine mouth rinse and the Neutrogena and Aveeno skin care lines contributed to operational sales growth during the quarter.
Additional financial data is available from the company.